Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-ND2 pseudogene 14 (MTND2P14) is a non-coding pseudogene listed in the HUGO Gene Nomenclature Committee (HGNC) database as a locus of mitochondrial origin[4]. Unlike its functional counterpart MT-ND2, which encodes a core subunit of mitochondrial NADH:ubiquinone oxidoreductase (Complex I), MTND2P14 is predicted to be non-functional and is not known to produce a protein product. It does not participate in mitochondrial electron transport or any characterized physiological or pathophysiological processes. There are no known drugs, biomarkers, or therapeutic implications directly associated with this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-ND2 pseudogene 14 (MTND2P14).